Pompe

Thank You!

The End

How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?

What makes avalglucosidase alfa different from alglucosidase alfa in terms of clinical efficacy and patient outcomes?

Advances in Therapy: Avalglucosidase Alfa & Future Innovations

What has been your experience with switching patients from alglucosidase alfa to avalglucosidase alfa?

Current Treatment Landscape & hands on Experience

What factors influence your decision to switch a patient from alglucosidase alfa to avalglucosidase alfa?

How can you see changing the lives of patient starting taking Nexviazyme and if you can share from your experience couple of patient stories that realy impacted positively from staring the treatment for Pompe disease?

From your experience

What challenges do clinicians face in monitoring in disease progrission and response to therapy?

Have you observed any significant differences in treatment outcomes between these two therapies in your local practice?

Pompe Care Podcast Series 2

Welcome to the Pompe Care podcast series. Today we speak with Dr. Rawda Sunbul, Consultant Medical Genetics at Qatif Central Hospital in Saudi Arabia, about Pompe disease. We discuss the typical patient journey and diagnostic challenges. Dr. Sunbul shares insights on new diagnostic technologies, effective ways to support patients and families, and how to address the social stigma surrounding rare diseases.

Pompe Care Podcast Series 3

Today we speak with Dr. Nadia Alhashmi, Senior Consultant in Chemical & Bio-Chemical Genetics at the National Genetics Royal Hospital in Oman, and Dr. Khalid Althihli, Senior Consultant in Chemical & Bio-Chemical Genetics at Sultan Qaboos University Hospital in Oman. With deep expertise in rare metabolic and genetic disorders, both specialists bring frontline clinical perspectives on Pompe disease — covering the typical patient journey, diagnostic challenges, and new diagnostic technologies, while sharing their compassionate approach to supporting patients and families and addressing the social stigma surrounding rare diseases.

When Weakness Tells a Bigger Story

It's Not Just A Wakness/ Dr. Ahmed Bamaga

The Many Faces of Limb-Girdle Weakness

Differentail Diagnosis for Unspecific Limb - Girdle Muscular Dystrophy (LGMD)/ Dr. Alanood Alsolaihim

Safety and efficacy of Avalglucosidase Alfa versus Alglucosidase Alfa in patints with Late-Onset Pompe Disease (COMET): a phase 3, randomized, multicentral study results

Long-term Safety and Efficacy of Avalglucosidase Alfa IN Patients with Late-Onset Pompe Disease (NEO-EXT)

Their Stories shaped them like Pearls

Pompe video

IOPD Challenges

Pompe Care Podcast Series

Welcome to Pompe Care podcast series, today’s episodes we speak to Dr. Amal Al Teneiji, Metabolic Genetics Consultant at Sheikh Khalifa Medical City Abu Dhabi, about Pompe disease. We talk about typical diagnosis of patient journey, challenges facing, new diagnostic technologies, effective ways to support patients and families and social stigma.

Early diagnosis and management of IOPD

Diagnostic challenges of LOPD

Have you considered Pompe Disease?

Prevalence of LOPD in patients with undifferentiated proximal myopathy and undiagnosed muscle biopsy

Pompe

Navigating the Pompe Disease Journey

Expert Group Consensus From the Arabian Peninsula On the Diagnosis of Lopd

Expert Group Consensus From the Arabian Peninsula On the Diagnosis of Lopd

Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease (LOPD)

Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease for orthopedists

Experts recommendations on Late Onset Pompe Disease (LOPD) differential diagnosis from GCC

Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography